Aindo Officially Joins AICROplus

We are pleased to announce that Aindo has officially become a member of AICROplus (the Italian Association of CROs and Service Providers for Clinical Research).

This important milestone sets a clear course for the future of the sector: integrating Artificial Intelligence (AI) and synthetic data generation into the heart of clinical research to foster an increasingly effective use of data, supporting healthcare innovation and accelerating the production of high-quality scientific evidence.

The industry is currently undergoing a profound transformation. The European Health Data Space (EHDS), the new ICH E6(R3) Good Clinical Practice guidelines, and the introduction of the Joint Clinical Assessment (JCA) are driving an increasingly collaborative research model based on the integration of specialized expertise, advanced methodologies, and complementary sources of evidence.

The goal of this synergy is to actively contribute to the technological and analytical development of the sector by sharing advanced competencies within a highly qualified community.

Through this collaboration, Aindo and AICROplus will work together across several strategic areas:

• Educational and Academic Initiatives: To promote a strong culture around data and AI applied to medicine.
• Events and Congresses: To showcase the latest technological and methodological advancements in the industry.
• Institutional Relations: To foster dialogue and collaboration with key stakeholders in the healthcare and pharmaceutical sectors.

Our shared commitment is to drive scientific innovation while consistently maintaining the most rigorous standards of privacy, ethics, transparency, and data integrity.